Dosage Form Development
Our formulation scientists are experienced in developing a wide variety of dosage forms. We evaluate dosage form options based on a compound’s preformulation study results during the early stages of product development, ensuring that the final product is tailored to meet the needs of your clinical program or your commercial market.
An effective, easy to administer dosage form can increase patient compliance and minimize dosing discrepancies during clinical trials. A change in dosage form can also offer a competitive advantage.
Formatech develops the following dosage forms:
- Parenterals: liquid, lyophilized
- High concentration monoclonal antibodies
- Controlled release: depot/microparticle formulations, liposomes, emulsions
- Oral: tablets, capsules, liquids
- Nebulized
- Topicals: gels, ointments, creams
